RENJUBLY
Live / Registered — Registered (as of 26 Aug 2025)
What this means for you
Registered since 26 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99008408
- Registration number
- 7921791
- Mark type
- Stylized text
- Filed
- 17 Jan 2025
- Published for opposition
- 08 Jul 2025
- Registered
- 26 Aug 2025
- Attorney of record
- Karl M. Zielaznicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and management of the central nervous system conditions; pharmaceutical preparations for the treatment and management of sleep disorders.
Owner
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
- Takeda Pharmaceuticals International AG, Glattpark-Opfikon, CH
Prosecution history
- 26 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2025 — ASSIGNED TO LIE
- 16 May 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 14 May 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 14 May 2025 — LETTER OF SUSPENSION E-MAILED
- 14 May 2025 — SUSPENSION LETTER WRITTEN
- 13 May 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — APPLICATION FILING RECEIPT MAILED